MEPERIDINE HYDROCHLORIDE INJECTION USP
SANDOZ CANADA INCORPORATED
Quick answers
Is there a shortage of MEPERIDINE HYDROCHLORIDE INJECTION USP in Canada?
No. There is no current shortage of MEPERIDINE HYDROCHLORIDE INJECTION USP 50MG reported to Health Canada. Stock can still vary from one pharmacy to another.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP: Out of Specification Test Result
Moderate health risk
Possible match — not confirmed
Dexmedetomidine Hydrochloride Injection
Dexmedetomidine Hydrochloride Injection: illegible lot number and expiry date on label
Low health risk
Possible match — not confirmed
DIN
00725765
Strength
50MG
Dosage Form
Solution
Route
Intravenous Intramuscular Subcutaneous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495937
DIN 02495910
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759